Russian Ministry of Health in accordance with Article 32 of the Federal Law of 12.04.2010 number 61-FZ "On Circulation of Medicines" decided to cancel state registration and exclusion from the state register of medicines for medical use of the drug(registration certificate P N011321 / 02 dated 09.12.2010 issued by Sanofi-Aventis Deutschland GmbH, Germany):
Tarivid® (trade name of the medicinal product)
Ofloxacin (international non-proprietary or chemical name of the drug)
solution for infusions, 2 mg / ml (dosage form, dosage)
Sanofi-Aventis Deutschland GmbH, Germany Brueningstrasse 50, D-65926 Frankfurt(Main), Germany (name and address of the location of the manufacturer of the medicinal product)
on the basis of an application by the authorized legal entity of the Sanofi-aventis Group JSC (France), Russia, to cancel the state registration of the medicinal product.